Proton therapy treatments are based on a proton RBE (relative biological effectiveness)
relative to high-energy photons of 1.1. The use of this generic, spatially invariant RBE within …

Ion acceleration driven by superintense laser pulses is attracting an impressive and steadily
increasing effort. Motivations can be found in the applicative potential and in the perspective …

The use of radiochromic film (RCF) dosimetry in radiation therapy is extensive due to its high
level of achievable accuracy for a wide range of dose values and its suitability under a …

Proton therapy treatments are currently planned and delivered using the assumption that the
proton relative biological effectiveness (RBE) relative to photons is 1.1. This assumption …

UHDpulse–Metrology for advanced radiotherapy using particle beams with ultra-high pulse
dose rates is a recently started European Joint Research Project with the aim to develop and …

Ultrahigh dose rate, FLASH radiotherapy has emerged as one of the most promising
innovations over the past decade in the field of radiation oncology, with the potential to …

The use of particle accelerators in radiotherapy has significantly changed the therapeutic
outcomes for many types of solid tumours. In particular, protons are well known for sparing …

The ultrashort duration of laser-driven multi-MeV ion bursts offers the possibility of
radiobiological studies at extremely high dose rates. Employing the TARANIS Terawatt laser …

The “Laser-hybrid Accelerator for Radiobiological Applications,” LhARA, is conceived as a
novel, flexible facility dedicated to the study of radiobiology. The technologies demonstrated …

Radiotherapy is a cornerstone of cancer management. The improvement of spatial dose
distribution in the tumor volume by minimizing the dose deposited in the healthy tissues …